Lecture 13 Flashcards
(7 cards)
Explain the types of ADRs
Type A (Augmented Dose related)
* Approximately 80% of ADRs→a consequence of the drug’s primary pharmacological effect (e.g., bleeding from warfarin) or low therapeutic index (nausea from digoxin)
* Type A ADRs are predictable.
* Dose-related and usually mild, may be serious or even fatal (e.g., intracranial bleeding from warfarin)
→usually due to inappropriate dosage, especially when drug elimination is impaired
* The term “side effects” is often applied to minor type A reactions.
Type B (Bizarre non dose related)
* The reactions are not predictable from the drug’s main pharmacological action.
* Not dose-related and are severe, with a considerable mortality
* The underlying pathophysiology is poor→often has a genetic or immunological basis
* The reactions occur infrequently (1:1,000-1:10,000 treated subjects being typical).
Type C (Dose- and Time-Related)
* Continuous reactions (chronic) due to long-term drug use
* E.g., neuroleptic-related tardive dyskinesia or analgesic nephropathy
Type D (Time-Related)
* Delayed reactions
* E.g., alkylating agents leading to carcinogenesis or retinoid-associated
teratogenesis
Type E
* * End-of-use reactions
* E.g. a. Adrenocortical insufficiency following withdrawal of glucocorticosteroids
DoTs Classifications
Dose-relatedness
a. Supratherapeutic reactions
→occur at doses higher than recommended
b. Collateral reactions
→occur at the recommended dose
c. Hypersensitivity reactions
→occur at lower doses than recommended
Time-relatedness
a. Fast reaction
→red man syndrome with vancomycin→pruritus and an erythematous
rash in the face, neck and thorax b. The first dose
→postural hypotension after administration of an ACE inhibitor c. Early→nitrate-induced headache
d. Intermediate→type II, III and IV hypersensitivity reactions
e. Late→typical antipsychotic-induced tardive dyskinesia
f. Delayed
→adenocarcinoma of the vagina associated with exposure in utero to diethylstilbestrol
Susceptibility
a. Genetic→e.g., patient bleeding with CYP2C9 polymorphism
b. Age→e.g., paediatric and older population
c. Gender→e.g., lupus erythematosus induced by drugs (more common in women)
d. Exogenous factor→e.g., drug interactions
e. Disease→e.g., hepatic or renal disease
Prevention from Adverse effects
- Identify the subgroup of patients who are likely to be susceptible to the adverse effect and modify the treatment choice accordingly
- Patients’ medication history will identify any previous ADRs and therefore preclude re-exposure to the drug
- Susceptibility factors→age, gender, pregnancy status and ethnicity can help predict the risk of ADR occurring
- Pharmacogenomic data?
- Treatment plan mitigates any possible adverse effects
* Prudent and safe prescribing is key to reducing errors that can contribute to ADRs
* Prescribe two drugs to mitigate the ADRs that could be caused by one of the drugs
The types of allergic reaction can be divided into
a. Type I: IgE-mediated drug hypersensitivity
* It is due to the production of reaginic (IgE) antibodies to an antigen.
b. Type II: IgG-mediated cytotoxicity
* It is due to antibodies of class IgG (predominating) and IgM
c. Type III: Immune-complex arthur reactions
* Circulating immune complexes can produce several clinical allergic states
d. Type IV: T-cell-mediated drug hypersensitivity
* The classical example of this reaction is contact dermatitis (e.g., topical antibiotics→penicillin and neomycin)
Prevention of Allergic Adverse Drug Reactions
- Taking a detailed drug history
→prescription and over-the-counter drugs, drugs of abuse, nutritional and vitamin supplements and
alternative remedies - Drugs given orally are less likely to cause severe ADRs than those given by injection.
- Desensitisation (hyposensitisation)→applies only when continued use of the drug is essential
- Prophylactic skin testing→not usually practicable, and a negative test does not exclude the possibility of an allergic reaction
Examples of other allergic reactions other than ADRs
- Rashes (Antimicrobial agents)
- Lymphadenopathy (Phenytoin)
- Blood Dyscrasias; Thrombocytopenia, anaemia (Heparin)
- Systematic Lupus Erythematosus (Hydralazine)
- Vasculitis (Acute = penicillins; Chronic = phenytoin)
- Renal Dysfunction (penicillamine)